Table 2 Therapeutic interventions in HUS in children in Norway, 1999–2008
Therapeutical interventions | Diarrhoea-associated HUS (N = 38) | Non-diarrhea-associated HUS (N = 9) |
|---|---|---|
Dialysis – any type (n, %) | 22 (58 %) | 3 (33 %) |
Type of dialysis (n) − Peritoneal (n, %) − Hemodialysis (n, %) − Both (n, %) | (N = 22) 6 (27 %) 13 (59 %) 3 (14 %) | (N = 3) 1 (33 %) 2 (66 %) 0 (0 %) |
Duration of dialysis (median, days) | 8 (5–15) (N = 22a) | 12 (7–13) (N = 3) |
Plasmapheresis (n, %) | 3 (8 %) | 1 (11 %) |
Red blood cell transfusion(s) (n, %) | 34 (89 %) | 9 (100 %) |
Platelet transfusion(s) (n, %) | 15 (39 %) | 3 (33 %) |
Plasma infusion(s) (n, %) | 6 (16 %) | 4 (44 %) |
Antibiotics – any indication (n, %) | 23 (61 %) | 4 (44 %) |
Ventilation therapy (n, %) | 9 (24 %) | 2 (22 %) |
ERCP (n, %) | 0 (0 %) | 1 (11 %) |
Cholecystostomy (n, %) | 1 (3 %) | 0 (0 %) |
Renal transplantation (n, %) | 1 (3 %)b | 0 (0 %) |